Prospective comparison of transthoracic versus transhiatal esophagectomy following neoadjuvant therapy for esophageal cancer

Diseases of the Esophagus

Volumn 20, Issue 3, 2007, Pages 225-231

  Morgan, M A ^a,b   Lewis, Wyn G ^a,b   Hopper, A N ^a,b   Escofet, X ^a   Havard, T J ^c   Brewster, A E ^d   Crosby, T D L ^d   Roberts, S A ^a   Clark, G W B ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

^c ROYAL GLAMORGAN HOSPITAL   (United Kingdom)

^d VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

Esophageal cancer; Neoadjuvant therapy; Surgery

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL DECISION MAKING; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL TIME; TRANSHIATAL ESOPHAGECTOMY; TRANSTHORACIC ESOPHAGECTOMY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34249733626     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00676.x     Document Type: Article

References (27)

1. Muller J M, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845-57.
2. Hulscher J B F, Tifssen J G P, Obertrop H, van Lanschot J J B. Transthoracic versus transhiatal resection for carcinoma of the esophagus: A meta-analysis. Ann Thorac Surg 2001; 72: 306-13.
3. Goldmine M, Maddern G, Le Prise E, Meunier B, Campion J P, Launois B. Oesophagectomy by a transhiatal approach or thoracotomy: A prospective randomized trial. Br J Surg 1993; 80: 367-70.
4. Chu K M, Law S Y, Fok M, Wong J. A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg 1997; 174: 320-4.
5. Jacobi C A, Zieren H U, Muller J M, Pichlmaier H. Surgical therapy of esophageal carcinoma: The influence of surgical approach and esophageal resection on cardiopulmonary function. Eur J Cardiothorac Surg 1997; 11: 32-7.
6. Hulscher J B F, van Sandwick J W, DE Boer A G E M et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347: 1662-9.
7. Lewis I. The surgical treatment of carcinoma of the oesophagus, with special reference to new operation for growths of middle third. Br J Surg 1946; 34: 18-31.
8. Tanner I C. The present position of carcinoma of the oesophagus. Postgrad Med J 1947; 23: 109-39.
9. Orringer M B. Transhiatal oesophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann Surg 1984; 200: 282-8.
10. Lerut T, DeLeyn P, Coosemans W, Van Raemdonck D, Scheys I, Le Saffre E. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992; 216: 583-90.
11. Heald R J, Moran B J, Ryall R D, Sexton R, MacFarlane J K. Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978-97. Arch Surg 1998; 133: 894-9.
12. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987; 11: 418-25.
13. Sue Ling H M, Johnston D, Martin I G et al. Gastric cancer: A curable disease in Britain. BMJ 1993; 307: 591-6.
14. Walsh N, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy T P J. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-7.
15. Bancewicz J, Clark P, Smith D et al. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomized controlled trial. Lancet 2002; 9319: 1727-33.
16. Welsh Index of Multiple Deprivation online http://www.wales.gov.uk/ keypubstatisticsforwales/content/publication/social/2000/deprivation/ intro_e.htm accessed 5.3.2004.
17. Akiyama H. Japanese Classification of Gastric Carcinoma. Japanese Research Society for Gastric Cancer, First English Edition. Tokyo: Kanehara & Co., Ltd.
18. Kennedy B J. The unified international gastric cancer staging classification. Scand J Gastroenterol 1987; 22 (Suppl. 133): 11-13.
19. Sobin L H, Wittekind C H, eds. UICC TNM Classification of Malignant Tumors, 5th edn. New York, USA: John Wiley and Sons, 1997.
20. Stephens M R, Brewster A E, Lewis W G et al. Multidisciplinary teams are associated with improved outcomes after esophagectomy for carcinoma. Dis Esophagus 2006; 19: 164-171.
21. Altman D G, ed. Practical Statistics for Medical Research. London, England: Chapman & Hall, 1991.
22. Kaplan E L, Meier P. Non-parametric estimation from incomplete observations. J Am Statistics Assoc 1958; 58: 457-81.
23. Rentz J, Bull D, Harpole D et al. Transthoracic versus transhiatal esophagectomy: A prospective study of 945 patients. J Thorac Cardiovasc Surg 2003; 125: 1114-20.
24. Sato N, kusama A, Ohkawa A et al. Resting energy expenditure in patients undergoing transhiatal or transthoracic oesophagectomy for carcinoma of the thoracic esophagus. Br J Surg 1993; 80: 1413-15.
25. Johansson J, DeMeester T R, Hagen J A et al. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus. Arch Surg 2004; 139: 627-3.
26. Suttton D N, Wayman J, Griffin S M. Learning curve for oesophageal cancer surgery. Br J Surg 1999; 85: 1399-402.
27. King P M, Blazeby J M, Gupta J, Alderson D, Moorghen M. Upper gastrointestinal cancer pathology reporting; a regional audit to compare standards with minimum datasets. J Clin Pathol 2004; 57: 702-5.